Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Life Science REIT PLC

Real Estate GB LABS

NoneGBX
0.00(0%)

Last update at 2026-05-19T16:00:46.612981Z

Day Range

--
LowHigh

52 Week Range

34.0049.00
LowHigh

Fundamentals

  • Previous Close 43.10
  • Market Cap141.05M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM21.04M
  • Revenue Per Share TTM0.06
  • Gross Profit TTM 15.19M
  • Diluted EPS TTM-0.09

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -13.97700M -21.85200M -27.46700M 7.74M
Minority interest - - - -
Net income -13.97700M -21.70600M -27.61300M 7.74M
Selling general administrative 7.71M 7.98M 7.55M 0.38M
Selling and marketing expenses - 0.67M - -
Gross profit 11.45M 10.44M -19.92000M 8.12M
Reconciled depreciation - - - -
Ebit - 28.08M 5.33M -0.72480M
Ebitda 9.78M 8.72M -27.46700M 7.74M
Depreciation and amortization - -19.35800M - -
Non operating income net other - - - -
Operating income 9.78M -14.58900M -27.46700M 7.74M
Other operating expenses 10.53M 34.53M 7.55M 0.38M
Interest expense 9.22M 11.07M 3.78M 0.00000M
Tax provision 0.00000M -0.14600M 0.15M 0.00000M
Interest income 6.09M 3.81M 3.25M 0.00700M
Net interest income -3.12700M -7.26300M -0.52700M 0.00700M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense - -0.14600M 0.15M -
Total revenue 20.31M 19.94M -19.92000M 8.12M
Total operating expenses 28.10M 34.53M 7.55M 0.38M
Cost of revenue 8.86M 9.51M - -
Total other income expense net -23.75800M -7.26300M - -
Discontinued operations - - - -
Net income from continuing ops -13.97700M -21.70600M -27.61300M 7.74M
Net income applicable to common shares - - - 18.58M
Preferred stock and other adjustments - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 401.19M 410.70M 447.82M 361.40M
Intangible assets - - - -
Earning assets - - - -
Other current assets -7.84200M -10.06500M 4.00M 1.39M
Total liab 138.42M 126.96M 128.37M 10.82M
Total stockholder equity 262.77M 283.75M 319.45M 350.58M
Deferred long term liab - - - -
Other current liab -2.59800M -3.68600M -1.02700M 9.31M
Common stock 3.50M 3.50M 3.50M 3.50M
Capital stock 3.50M 3.50M 3.50M 3.50M
Retained earnings -55.55500M -41.57800M -19.87200M 7.74M
Other liab - - - -
Good will - - - -
Other assets 401.19M 410.70M 422.55M -
Cash 5.57M 14.34M 10.61M 165.96M
Cash and equivalents - - - -
Total current liabilities - 1.82M 1.03M 10.82M
Current deferred revenue - 3.69M - -
Net debt 116.67M 93.58M 99.22M -165.96200M
Short term debt - - - -
Short long term debt - - - -
Short long term debt total 122.24M 107.92M 109.83M -
Other stockholder equity 314.82M - 335.82M 339.34M
Property plant equipment - - - 192.17M
Total current assets 5.57M 14.34M 20.97M 166.94M
Long term investments 2.38M 4.00M 4.30M -
Net tangible assets - - - 350.58M
Short term investments - - - -
Net receivables 7.84M 10.06M 10.37M 0.98M
Long term debt - - - -
Inventory - - - -
Accounts payable 2.57M 1.82M 1.03M -
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income 314.82M 321.82M - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other -2.37800M 10.06M -4.30300M -
Deferred long term asset charges - - - -
Non current assets total 2.38M 396.36M 4.30M -
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -16.35000M -11.64300M -186.37800M -181.51700M
Change to liabilities - - 0.00000M 0.00000M
Total cashflows from investing activities -16.35000M -11.64300M - -435.64080M
Net borrowings 14.00M -2.78400M - -
Total cash from financing activities -5.34500M -27.23700M 67.11M 343.94M
Change to operating activities - - - 17.02M
Net income -7.79000M -21.70600M -26.94000M 7.73M
Change in cash -8.77400M -31.26500M -120.35600M 165.96M
Begin period cash flow 14.34M 45.61M 165.96M 0.00000M
End period cash flow 5.57M 14.34M 45.61M 165.96M
Total cash from operating activities 12.92M 7.62M -1.08800M 3.54M
Issuance of capital stock - - 0.00000M 350.00M
Depreciation - - - -
Other cashflows from investing activities 2.93M 12.39M - 0.02M
Dividends paid 7.00M 14.00M 3.50M 0.00000M
Change to inventory - -4.21600M - -
Change to account receivables 3.91M -5.17700M - -7.60560M
Sale purchase of stock - - - -
Other cashflows from financing activities -12.34500M -10.45300M 96.87M -6.05900M
Change to netincome - - - -19.50000M
Capital expenditures 19.28M 24.03M 7.64M 7.64M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital 3.33M -0.96100M -5.46000M 3.92M
Stock based compensation - - - -
Other non cash items 17.38M 30.28M 31.31M -8.11800M
Free cash flow -6.35900M -16.41900M -1.08800M 3.54M

Peer Comparison

Sector: Real Estate Industry: REIT - Healthcare Facilities

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
LABS
Life Science REIT PLC		 - -% - - - 6.65 0.60
PHP
Primary Health Properties		 0.45 0.50% 91.25 13.53 12.52 9.49 0.94 25.47
THRL
Target Healthcare REIT Ltd		 -0.4 0.38% 104.60 8.09 15.72 8.75 0.89 10.23 26.25

Reports Covered

Stock Research & News

View All

Profile

Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.

Life Science REIT PLC

Central Square, Leeds, United Kingdom, LS1 4DL

Key Executives

Name Title Year Born
Mr. Simon Farnsworth Managing Director NA
Tamara Deering Head of Financial Planning & Reporting NA
Mr. David Lewis Director of Operations & Fin. NA
Ms. Stephanie Adams Legal Counsel NA
Dr. Sally Ann Forsyth O.B.E., Ph.D. Independent Non-Exec. Director & Sustainability Lead NA
Mr. Ian Harris Director of Asset Management NA
Ms. Pippa Stacey Head of ESG & Consultant NA
Daniel Williams Corp. & Devel. Financial Controller NA
Mr. Simon Mark Farnsworth Managing Director of Ironstone Asset Management Limited 1967
Mr. David Lewis Director of Operations & Finance of Ironstone Asset Management Limited NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions